Insider · CIK 0001278388

Bradsher Neal C

Reports to the SEC for 7 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001278388

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-01	LCTXLineage Cell Therapeutics, Inc. · OPTION TO PURCHASE COMMON SHARESA Award	Director, 10% Owner	AAward	+125K sh	—	—	125,000
2026-06-18	STAASTAAR SURGICAL CO · OPTION TO PURCHASE COMMON STOCKA Award	Director, 10% Owner	AAward	+11.1K sh	—	—	11,145
2026-03-06	STAASTAAR SURGICAL CO · OPTION TO PURCHASE COMMON STOCKA Award	Director, 10% Owner	AAward	+7,524 sh	—	—	7,524
2025-07-01	LCTXLineage Cell Therapeutics, Inc. · OPTION TO PURCHASE COMMON SHARESA Award	Director, 10% Owner	AAward	+75K sh	—	—	75,000
2024-07-01	LCTXLineage Cell Therapeutics, Inc. · OPTION TO PURCHASE COMMON SHARESA Award	Director, 10% Owner	AAward	+75K sh	—	—	75,000
2023-07-01	LCTXLineage Cell Therapeutics, Inc. · OPTION TO PURCHASE COMMON SHARESA Award	Director, 10% Owner	AAward	+50K sh	—	—	50,000
2022-07-01	LCTXLineage Cell Therapeutics, Inc. · OPTION TO PURCHASE COMMON SHARESA Award	Director, 10% Owner	AAward	+50K sh	—	—	50,000
2021-07-01	LCTXLineage Cell Therapeutics, Inc. · OPTION TO PURCHASE COMMON SHARESA Award	Director, 10% Owner	AAward	+50K sh	—	—	50,000
2021-06-25	LCTXLineage Cell Therapeutics, Inc. · OPTION TO PURCHASE COMMON SHARESM Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−24.7K sh	—	—	0
2021-06-25	LCTXLineage Cell Therapeutics, Inc.M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+24.7K sh	$2.20	+$54.4K	87,628
2020-07-01	LCTXLineage Cell Therapeutics, Inc. · OPTION TO PURCHASE COMMON SHARESA Award	Director, 10% Owner	AAward	+40K sh	—	—	40,000
2019-07-01	LCTXLineage Cell Therapeutics, Inc. · OPTION TO PURCHASE COMMON SHARESA Award	Director, 10% Owner	AAward	+40K sh	—	—	40,000
2018-07-01	LCTXLineage Cell Therapeutics, Inc. · OPTION TO PURCHASE COMMON SHARESA Award	Director, 10% Owner	AAward	+40K sh	—	—	40,000
2017-07-01	LCTXLineage Cell Therapeutics, Inc. · OPTION TO PURCHASE COMMON SHARESA Award	Director, 10% Owner	AAward	+20K sh	—	—	20,000
2016-07-01	LCTXLineage Cell Therapeutics, Inc. · OPTION TO PURCHASE COMMON SHARESA Award	Director, 10% Owner	AAward	+20K sh	—	—	20,000
2015-07-01	LCTXLineage Cell Therapeutics, Inc. · OPTION TO PURCHASE COMMON SHARESA Award	Director, 10% Owner	AAward	+20K sh	—	—	20,000
2014-07-01	LCTXLineage Cell Therapeutics, Inc. · OPTION TO PURCHASE COMMON SHARESA Award	Director, 10% Owner	AAward	+20K sh	—	—	20,000
2014-06-30	LCTXLineage Cell Therapeutics, Inc. · Option To Purchase Common SharesM Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−20K sh	—	—	0
2014-06-30	LCTXLineage Cell Therapeutics, Inc.M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+20K sh	$2.30	+$46K	62,908
2013-12-30	LCTXLineage Cell Therapeutics, Inc.P Purchase	Director, 10% Owner	PPurchase	0 sh	—	—	9,322,262
2013-12-30	LCTXLineage Cell Therapeutics, Inc.P Purchase	Director, 10% Owner	PPurchase	+175K sh	$3.49	+$611K	9,322,262
2013-12-27	LCTXLineage Cell Therapeutics, Inc.P Purchase	Director, 10% Owner	PPurchase	0 sh	—	—	9,147,262
2013-12-27	LCTXLineage Cell Therapeutics, Inc.P Purchase	Director, 10% Owner	PPurchase	+56K sh	$3.53	+$198K	9,147,262
2013-12-26	LCTXLineage Cell Therapeutics, Inc.P Purchase	Director, 10% Owner	PPurchase	0 sh	—	—	9,091,262
2013-12-26	LCTXLineage Cell Therapeutics, Inc.P Purchase	Director, 10% Owner	PPurchase	+69K sh	$3.53	+$244K	9,091,262
2013-11-14	QUESTCOR PHARMACEUTICALS INCS Sale	Director	SSale	−25K sh	$62.46	−$1.56M	4,183
2013-11-14	QUESTCOR PHARMACEUTICALS INCOPTION TO PURCHASE COMMON SHARESM Exercise/Conversion	Director	MExercise/Conversion	−25K sh	—	—	0
2013-11-14	QUESTCOR PHARMACEUTICALS INCOPTION TO PURCHASE COMMON SHARESM Exercise/Conversion	Director	MExercise/Conversion	−15K sh	—	—	0
2013-11-14	QUESTCOR PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+15K sh	$0.90	+$13.5K	19,183
2013-11-14	QUESTCOR PHARMACEUTICALS INCM Exercise/Conversion	Director	MExercise/Conversion	+25K sh	$0.83	+$20.8K	44,183
2013-11-14	QUESTCOR PHARMACEUTICALS INCS Sale	Director	SSale	−15K sh	$62.31	−$935K	29,183
2013-07-01	LCTXLineage Cell Therapeutics, Inc. · OPTION TO PURCHASE COMMON SHARESA Award	Director, 10% Owner	AAward	+20K sh	—	—	20,000
2013-05-24	QUESTCOR PHARMACEUTICALS INCStock Option (right to purchase)A Award	Director	AAward	+9,203 sh	—	—	9,203
2013-05-24	QUESTCOR PHARMACEUTICALS INCA Award	Director	AAward	+4,183 sh	—	—	4,183
2012-05-10	QUESTCOR PHARMACEUTICALS INCStock Option (right to purchase)A Award	Director	AAward	+15.2K sh	—	—	290,214
2011-01-01	QUESTCOR PHARMACEUTICALS INCSTOCK OPTION (Right to Buy)A Award	Director	AAward	+7,500 sh	—	—	250,000
2011-01-01	QUESTCOR PHARMACEUTICALS INCSTOCK OPTION (Right to Buy)A Award	Director	AAward	+10K sh	—	—	260,000
2011-01-01	QUESTCOR PHARMACEUTICALS INCSTOCK OPTION (Right to Buy)A Award	Director	AAward	+15K sh	—	—	275,000
2010-05-07	LCTXLineage Cell Therapeutics, Inc. · WARRANTSX Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	−1.1M sh	—	—	0
2010-05-07	LCTXLineage Cell Therapeutics, Inc. · WARRANTSX Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	0 sh	—	—	0
2010-05-07	LCTXLineage Cell Therapeutics, Inc. · WARRANTSX Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	0 sh	—	—	0
2010-05-07	LCTXLineage Cell Therapeutics, Inc. · WARRANTSX Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	−1.1M sh	—	—	0
2010-05-07	LCTXLineage Cell Therapeutics, Inc.X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	0 sh	—	—	6,869,249
2010-05-07	LCTXLineage Cell Therapeutics, Inc.X Exercise of In-Money	Director, 10% Owner	XExercise of In-Money	+2.2M sh	$1.82	+$4M	6,869,249
2010-01-01	QUESTCOR PHARMACEUTICALS INCSTOCK OPTION (Right to Buy)A Award	Director	AAward	+7,500 sh	—	—	217,500
2010-01-01	QUESTCOR PHARMACEUTICALS INCSTOCK OPTION (Right to Buy)A Award	Director	AAward	+15K sh	—	—	242,500
2010-01-01	QUESTCOR PHARMACEUTICALS INCSTOCK OPTION (Right to Buy)A Award	Director	AAward	+10K sh	—	—	227,500
2009-07-02	LCTXLineage Cell Therapeutics, Inc. · Option to purchase common sharesA Award	Director, 10% Owner	AAward	+20K sh	—	—	20,000
2009-01-01	QUESTCOR PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	210,000
2009-01-01	QUESTCOR PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+7,500 sh	—	—	185,000

Recent filings

Accepted (ET)
Jul 24
Bradsher Neal C0000919574-26-004259
SEC(opens sec.gov)
Jun 224
Bradsher Neal C0000919574-26-004068
SEC(opens sec.gov)
Mar 104
Bradsher Neal C0000919574-26-001546
SEC(opens sec.gov)
Jul 34
Bradsher Neal C0000919574-25-003973
SEC(opens sec.gov)
Jul 34
BRADSHER NEAL C0000919574-24-003898
SEC(opens sec.gov)
Jul 34
BRADSHER NEAL C0000919574-23-003906
SEC(opens sec.gov)
Jul 64
BRADSHER NEAL C0000919574-22-004056
SEC(opens sec.gov)
Jul 14
BRADSHER NEAL C0000919574-21-004361
SEC(opens sec.gov)
Jun 254
BRADSHER NEAL C0000919574-21-004286
SEC(opens sec.gov)
Jul 24
BRADSHER NEAL C0000919574-20-004437
SEC(opens sec.gov)
Jul 34
BRADSHER NEAL C0000919574-19-004450
SEC(opens sec.gov)
Jul 34
BRADSHER NEAL C0000919574-18-004518
SEC(opens sec.gov)
Jul 54
BIOTIME INC0000919574-17-005170
SEC(opens sec.gov)
Jul 54
BIOTIME INC0000919574-16-013938
SEC(opens sec.gov)
Jul 64
BIOTIME INC0000919574-15-005229
SEC(opens sec.gov)
Jul 34
BIOTIME INC0000919574-14-003914
SEC(opens sec.gov)
Jul 24
BIOTIME INC0000919574-14-003904
SEC(opens sec.gov)
Dec 304
BIOTIME INC0000919574-13-007044
SEC(opens sec.gov)

Companies

Address

C/O BROADWOOD CAPITAL, INC. 156 WEST 56TH STREET, 3RD FLOOR

NEW YORK, NY, 10019